Search research articles
Contact Us
Filters
Showing results (11-20 of 114) with videos related to
Page
of 12
Sort By:
Journal of Clinical Psychopharmacology
|
June 18, 2008
Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. Introduction
John S Markowitz, Kennerly S Patrick
Journal of Clinical Psychopharmacology
|
June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?
John S Markowitz, Kennerly S Patrick
Planta Medica
|
July 21, 2012
Limitations of in vitro assessments of the drug interaction potential of botanical supplements
John S Markowitz, Hao-Jie Zhu
Child and Adolescent Psychiatric Clinics of North America
|
June 13, 2022
The Pharmacokinetics and Pharmacogenomics of Psychostimulants
John S Markowitz, Philip W Melchert
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 6, 2019
In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites
Yuli Qian, Xinwen Wang, John S Markowitz
Journal of Clinical Psychopharmacology
|
August 22, 2019
The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
Yuli Qian, Bill J Gurley, John S Markowitz
Chemico-Biological Interactions
|
August 14, 2022
In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir
Qingchen Zhang, Philip W Melchert, John S Markowitz
Journal of Child and Adolescent Psychopharmacology
|
February 10, 2016
Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition
Guo Yu, Guo-Fu Li, John S Markowitz
CNS Spectrums
|
July 13, 2025
Central nervous system stimulants in recreational and medical use
Seetal Dodd, Laura Ospina-Pinillos, John S Markowitz
Medical Cannabis and Cannabinoids
|
January 31, 2024
Pharmacokinetic Variability of Oral Cannabidiol and Its Major Metabolites after Short-Term High-Dose Exposure in Healthy Subjects
Qingchen Zhang, Philip W Melchert, John S Markowitz
Page
of 12
Search research articles
Search
Showing results (11-20 of 114) with videos related to
Sort By:
Page
of 12
Journal of Clinical Psychopharmacology
|
June 18, 2008
Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. Introduction
John S Markowitz, Kennerly S Patrick
Journal of Clinical Psychopharmacology
|
June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?
John S Markowitz, Kennerly S Patrick
Planta Medica
|
July 21, 2012
Limitations of in vitro assessments of the drug interaction potential of botanical supplements
John S Markowitz, Hao-Jie Zhu
Child and Adolescent Psychiatric Clinics of North America
|
June 13, 2022
The Pharmacokinetics and Pharmacogenomics of Psychostimulants
John S Markowitz, Philip W Melchert
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 6, 2019
In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites
Yuli Qian, Xinwen Wang, John S Markowitz
Journal of Clinical Psychopharmacology
|
August 22, 2019
The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
Yuli Qian, Bill J Gurley, John S Markowitz
Chemico-Biological Interactions
|
August 14, 2022
In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir
Qingchen Zhang, Philip W Melchert, John S Markowitz
Journal of Child and Adolescent Psychopharmacology
|
February 10, 2016
Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition
Guo Yu, Guo-Fu Li, John S Markowitz
CNS Spectrums
|
July 13, 2025
Central nervous system stimulants in recreational and medical use
Seetal Dodd, Laura Ospina-Pinillos, John S Markowitz
Medical Cannabis and Cannabinoids
|
January 31, 2024
Pharmacokinetic Variability of Oral Cannabidiol and Its Major Metabolites after Short-Term High-Dose Exposure in Healthy Subjects
Qingchen Zhang, Philip W Melchert, John S Markowitz
Page
of 12